These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 22158075

  • 41. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Sanjay P, de Figueiredo RS, Leaver H, Ogston S, Kulli C, Polignano FM, Tait IS.
    JOP; 2012 Mar 10; 13(2):199-204. PubMed ID: 22406601
    [Abstract] [Full Text] [Related]

  • 42. Ataxia-telangiectasia-mutated protein kinase levels stratify patients with pancreatic adenocarcinoma into prognostic subgroups with loss being a strong indicator of poor survival.
    Kamphues C, Bova R, Bahra M, Klauschen F, Muckenhuber A, Sinn BV, Warth A, Goeppert B, Endris V, Neuhaus P, Weichert W, Stenzinger A.
    Pancreas; 2015 Mar 10; 44(2):296-301. PubMed ID: 25423555
    [Abstract] [Full Text] [Related]

  • 43. Neoplastic spindle cells are an independent prognostic factor in pancreatic cancer.
    Takahashi K, Hisaka T, Horiuchi H, Ishikawa H, Nakayama M, Nakashima O, Kawahara A, Kage M, Yano H, Akagi Y, Yonemoto K, Kinoshita H, Shirouzu K.
    Pancreas; 2015 Jul 10; 44(5):742-9. PubMed ID: 25931259
    [Abstract] [Full Text] [Related]

  • 44. Molecular biomarkers for progression of intraductal papillary mucinous neoplasm of the pancreas.
    Kuboki Y, Shimizu K, Hatori T, Yamamoto M, Shibata N, Shiratori K, Furukawa T.
    Pancreas; 2015 Mar 10; 44(2):227-35. PubMed ID: 25423558
    [Abstract] [Full Text] [Related]

  • 45. Epithelial-mesenchymal transition (EMT) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancer.
    Javle MM, Gibbs JF, Iwata KK, Pak Y, Rutledge P, Yu J, Black JD, Tan D, Khoury T.
    Ann Surg Oncol; 2007 Dec 10; 14(12):3527-33. PubMed ID: 17879119
    [Abstract] [Full Text] [Related]

  • 46. Tumor budding is an independent adverse prognostic factor in pancreatic ductal adenocarcinoma.
    O'Connor K, Li-Chang HH, Kalloger SE, Peixoto RD, Webber DL, Owen DA, Driman DK, Kirsch R, Serra S, Scudamore CH, Renouf DJ, Schaeffer DF.
    Am J Surg Pathol; 2015 Apr 10; 39(4):472-8. PubMed ID: 25634751
    [Abstract] [Full Text] [Related]

  • 47. Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas.
    Handra-Luca A, Hong SM, Walter K, Wolfgang C, Hruban R, Goggins M.
    Br J Cancer; 2011 Apr 12; 104(8):1296-302. PubMed ID: 21448168
    [Abstract] [Full Text] [Related]

  • 48. High toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer patients.
    Leppänen J, Helminen O, Huhta H, Kauppila JH, Isohookana J, Haapasaari KM, Lehenkari P, Saarnio J, Karttunen TJ.
    Virchows Arch; 2017 Apr 12; 470(4):401-410. PubMed ID: 28191612
    [Abstract] [Full Text] [Related]

  • 49. Recurrence and survival after surgery for pancreatic cancer with or without acute pancreatitis.
    Feng Q, Li C, Zhang S, Tan CL, Mai G, Liu XB, Chen YH.
    World J Gastroenterol; 2019 Oct 21; 25(39):6006-6015. PubMed ID: 31660036
    [Abstract] [Full Text] [Related]

  • 50. Keap1 expression has independent prognostic value in pancreatic adenocarcinomas.
    Isohookana J, Haapasaari KM, Soini Y, Karihtala P.
    Diagn Pathol; 2015 Apr 16; 10():28. PubMed ID: 25879528
    [Abstract] [Full Text] [Related]

  • 51. Prognostic significance of grade of malignancy based on histopathological differentiation and Ki-67 in pancreatic ductal adenocarcinoma.
    Liang Y, Sheng G, Guo Y, Zou Y, Guo H, Li Z, Chang S, Man Q, Gao S, Hao J.
    Cancer Biol Med; 2024 Jan 03; 21(5):416-32. PubMed ID: 38172499
    [Abstract] [Full Text] [Related]

  • 52. Systematic review of peri-operative prognostic biomarkers in pancreatic ductal adenocarcinoma.
    Petrushnko W, Gundara JS, De Reuver PR, O'Grady G, Samra JS, Mittal A.
    HPB (Oxford); 2016 Aug 03; 18(8):652-63. PubMed ID: 27485059
    [Abstract] [Full Text] [Related]

  • 53. Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions.
    Adham M, Jaeck D, Le Borgne J, Oussoultzouglou E, Chenard-Neu MP, Mosnier JF, Scoazec JY, Mornex F, Partensky C.
    Pancreas; 2008 Nov 03; 37(4):352-7. PubMed ID: 18665012
    [Abstract] [Full Text] [Related]

  • 54. Smad4 loss in esophageal adenocarcinoma is associated with an increased propensity for disease recurrence and poor survival.
    Singhi AD, Foxwell TJ, Nason K, Cressman KL, McGrath KM, Sun W, Bahary N, Zeh HJ, Levy RM, Luketich JD, Davison JM.
    Am J Surg Pathol; 2015 Apr 03; 39(4):487-95. PubMed ID: 25634752
    [Abstract] [Full Text] [Related]

  • 55. Improved long-term outcomes after resection of pancreatic adenocarcinoma: a comparison between two time periods.
    Serrano PE, Cleary SP, Dhani N, Kim PT, Greig PD, Leung K, Moulton CA, Gallinger S, Wei AC.
    Ann Surg Oncol; 2015 Apr 03; 22(4):1160-7. PubMed ID: 25348784
    [Abstract] [Full Text] [Related]

  • 56. High c-Met expression in stage I-II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correlation with poor prognosis.
    Neuzillet C, Couvelard A, Tijeras-Raballand A, de Mestier L, de Gramont A, Bédossa P, Paradis V, Sauvanet A, Bachet JB, Ruszniewski P, Raymond E, Hammel P, Cros J.
    Histopathology; 2015 Nov 03; 67(5):664-76. PubMed ID: 25809563
    [Abstract] [Full Text] [Related]

  • 57. Overexpression of FOXM1 is associated with poor prognosis and clinicopathologic stage of pancreatic ductal adenocarcinoma.
    Xia JT, Wang H, Liang LJ, Peng BG, Wu ZF, Chen LZ, Xue L, Li Z, Li W.
    Pancreas; 2012 May 03; 41(4):629-35. PubMed ID: 22249132
    [Abstract] [Full Text] [Related]

  • 58. Expression of microRNA-218 in human pancreatic ductal adenocarcinoma and its correlation with tumor progression and patient survival.
    Zhu Z, Xu Y, Du J, Tan J, Jiao H.
    J Surg Oncol; 2014 Feb 03; 109(2):89-94. PubMed ID: 24166773
    [Abstract] [Full Text] [Related]

  • 59. Preoperative fecal elastase-1 is a useful prognostic marker following curative resection of pancreatic cancer.
    Lim JH, Park JS, Yoon DS.
    HPB (Oxford); 2017 May 03; 19(5):388-395. PubMed ID: 28286044
    [Abstract] [Full Text] [Related]

  • 60. Mucin expression in endoscopic ultrasound-guided fine-needle aspiration specimens is a useful prognostic factor in pancreatic ductal adenocarcinoma.
    Higashi M, Yokoyama S, Yamamoto T, Goto Y, Kitazono I, Hiraki T, Taguchi H, Hashimoto S, Fukukura Y, Koriyama C, Mataki Y, Maemura K, Shinchi H, Jain M, Batra SK, Yonezawa S.
    Pancreas; 2015 Jul 03; 44(5):728-34. PubMed ID: 25906442
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.